Illegal Sale of E-cigarettes Persists in Lucknow Despite Ban

Feb.19.2025
Illegal Sale of E-cigarettes Persists in Lucknow Despite Ban
Despite India's ban on e-cigarette sales, shops in Lucknow openly defy the law, offering delivery services and various flavors.

According to a report by Hindustan Times on February 18, despite the ban on production, sale, import, export, transportation, and promotion of e-cigarettes in India having taken effect, the devices are still openly being sold.

 

The Indian government banned the sale of e-cigarettes on September 18, 2019, but vendors continue to sell these products through small shops and grocery stores. According to an investigation by the Hindustan Times, there are quite a few shops not only selling e-cigarettes, but also offering home delivery services, easily bypassing legal restrictions. During a field investigation in Lucknow Division in Indira from February 15th to 16th, Hindustan Times found at least four to five shops openly selling e-cigarettes, where the shop owners introduce and sell various flavors of e-cigarettes and disposable e-cigarettes ranging from 6,000 to 30,000 puffs.

 

A vendor at Janpath Market said that he can deliver e-cigarettes across the city for no extra charge. It is reported that 6,000 puffs of e-cigarettes are priced at 1,400 rupees (16 USD), while 30,000 are 2,400 rupees (28 USD). Multiple flavors are available, and discreet delivery is even possible upon request.

 

Another vendor is selling e-cigarettes with a starting capacity of 10,000 puffs for 1,600 rupees (18 USD) and is offering home delivery services. However, he stated that once sold, refunds or exchanges would not be supported.

 

In another area, a seller confirmed the supply of e-cigarettes and stated that customers can place orders over the phone, make payments using UPI, and get home delivery services. Compared to the Delhi market, e-cigarettes are harder to get supplies and a lower price in Lucknow. Currently, the main brands in Lucknow are IGET and ELFBAR.

 

Vijay Pratap Singh, Assistant Commissioner of the Food Safety and Drug Administration (FSDA) in Lucknow, stated that the FSDA will issue warnings to illegal vendors, and if they do not comply, their products will be sealed and banned for sale. However, the current regulations do not have sufficient penalties, as offenders only need to pay a fine of 200 rupees (2 dollars) per item to avoid harsher punishment. Additionally, the police have the authority to independently crackdown on these illegal activities.

 

Previously, 2Firsts had an exclusive interview with Kartik Laijawala, the CEO of Nico Orgo, which is the top nicotine enterprise in India, sharing his opinions about the trend of stricter regulations on sythetic nicotine, the ban of disposable e-cigarettes, etc. For more information, please refer to the full report: As Nicotine Markets Shift, Nico Orgo Bets on Natural Purity and Global Supply – A 2Firsts Interview. 

Illegal Sale of E-cigarettes Persists in Lucknow Despite Ban
Kartik Laijawala, the CEO of Nico Orgo | Source: 2Firsts

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Holdings said the U.S. Food and Drug Administration notified the company on June 23, 2026, that 30 PACHA vape SKUs with submitted PMTAs had been tentatively identified for inclusion on a planned public-facing FDA webpage. Under enforcement guidance issued by FDA in May, the webpage is intended to identify certain unauthorized products for which the agency generally does not intend to prioritize enforcement of premarket authorization requirements. Charlie’s disclosed the development alongside second-quarter revenue of $3.8 million, up 116% year over year.
Aug.25
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
Former BAT global content lead Andy Parton has left the company and launched Destreza, a London-based AI-native marketing consultancy. Parton previously worked across BAT's New Category brands Vuse, Velo and glo and had also served as Global Brand Lead for Vuse Go. Destreza says it will advise consumer businesses on AI in brand strategy, operating models, capability and agency configuration, using specialist AI agents to support research, strategy and creative development. BAT reported £3.621 billion in New Category revenue in 2025.
Sep.22